New radiation therapy shows promise for Tough-to-Treat prostate cancer
NCT ID NCT05720130
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new treatment called [212Pb]Pb-ADVC001 for men with prostate cancer that has spread to other parts of the body. The treatment delivers a small amount of radiation directly to cancer cells. The study has two parts: first, finding the safest and most effective dose, and then testing that dose in a larger group of 100 participants to see if it can shrink tumors and slow the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Gold Coast University Hospital
RECRUITINGSouthport, Queensland, 4215, Australia
-
Princess Alexandra Hospital
RECRUITINGBrisbane, Queensland, 4102, Australia
-
Royal Brisbane & Women's Hospital
RECRUITINGBrisbane, Queensland, 4029, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Chemo combo vs. radioactive drug: which tames aggressive prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can a new pill outsmart resistant prostate cancer?
- A second look: MRI screening may spot hidden prostate cancers
- Can a radioactive 'Smart Bomb' outsmart advanced prostate cancer?